Many recent studies of latent herpes simplex virus type 1 (HSV-1) infections within the nervous system have focused on the diploid genes encoding the latency-associated transcripts (LATs). The impaired explant reactivation of LAT variants from mouse trigeminal ganglia has implicated the LATs in the efficiency or 8:505-511, 1989). However, it is not known how closely explant reactivation mimics the reactivation process in vivo. In the current study, a LAT variant (1704), parental strain (17+), and rescuant (1704R) were compared in vivo for reactivation of latent infection by iontophoresis in the rabbit eye model and in vitro by explant cocultivation of trigeminal ganglia from rabbits. Following iontrophoresis, 17+ and 1704R reactivated in vivo from 76 and 64% of rabbits, respectively, while 1704 reactivated only from 4% (1 of 25) of the animals. In explant reactivation experiments, 17+ and 1704R reactivated from 98 and 67% of rabbit trigeminal ganglia, while 1704 reactivated from only 28% of trigeminal ganglia. The mean time required for the appearance of reactivated 1704 in explant culture, 17 days, was significantly longer than for 17+ and 1704R, 8 to 9 days. Thus, the explant reactivation kinetics in rabbit trigeminal ganglia reflect the behavior of LAT variant 1704 in vivo in the rabbit eye model. These data support the role of the LATs in the reactivation process and support the hypothesis that explant reactivation is a suitable system for analyzing the biological behavior of HSV-1 variants with defined genetic alterations in the LAT gene.
After primary infection with herpes simplex virus (HSV), a latent state is established in neural (4) and perhaps also in nonneural tissue (16) . Many herpetic diseases are the result of reactivation of latent virus; these can be life threatening in immunosuppressed individuals. The mechanisms of latency and reactivation have not been elucidated, although several experimental methods have been utilized to intentionally reactivate latent virus (6, 30, 31) .
HSV type 1 (HSV-1) transcription during latency, as studied by in situ hybridization, is limited to a 10-kb region within the long repeat regions ( Fig. 1) (1, 2, 5, 15, 21, 28, 29) . Three herpesvirus-specific RNAs (latency-associated transcripts, LATs) are detectable by Northern blot (RNA) analysis and map to a 3-kb location within the region positive by in situ hybridization (21, 23, 29) . Recently, Farrell et al. (3) have suggested that the 2.0-kb RNA is an intron from a larger transcript. The LATs are encoded by a diploid gene, overlap with the immediate early gene ICPO, and are transcribed in the opposite direction (21, 23, 29) . The LATs are present in reduced amounts in acutely infected mice (24) and infected tissue culture cells (23) and may represent a new kinetic class of HSV-1 genes (25) .
HSV-1 variants and mutants have been used to investigate the function and importance of the LATs during several stages of herpesvirus infection (10, 11, 13, 27 studies of HSV-1 variants and mutants, it has been demonstrated that the LATs are not required for viral replication in tissue culture or in animal models or for the establishment or maintenance of a latent infection. These HSV-1 mutants, which do not express the LATs, establish latent infections in mouse peripheral sensory or trigeminal ganglia and reactivate following explant. HSV-1 strain 17+ variant 1704 (12, 14) , which has a 3.5-kb deletion in the internal long repeat (IRL) and adjacent unique region and a 0.9-kb deletion in the terminal long repeat (TRL) (Fig. 1) , does not express any detectable LATs during latency (27) . In mice, variant 1704 established latency; however, following trigeminal ganglion explant, the time required for the LAT minus strain 1704 to reactivate was significantly greater than for parental strain 17+, implying that the deleted genetic information in 1704 modified the reactivation process in vitro and that the LATs may have a functional role during reactivation in vivo (27) .
An HSV-1 strain KOS-derived LAT deletion mutant, which lacks the LAT promoter, also reactivated inefficiently from explanted mouse trigeminal ganglia (13 Figure  2 shows an autoradiograph of 32P-labeled DNA from strains 17+, 1704, and 1704R which demonstrates that 1704R is repaired in the lesions of 1704. The 0.9-kb deletion in the terminal repeat copy of the LAT results in a noticeable shift of the j fragment to the j* position (Fig. 2, lane 2) . However, when the 0.9-kb deletion is present in the two large joint fragments b (j plus h) and e (j plus 1), only a small shift is observed. The 3.5-kb deletion in the internal repeat copy of the LAT results in the shift of fragment f to coincide with fragments g. The joint fragment a (f plus h) shifts to the position of b, which has moved to the position of c (f plus 1), and c has shifted to coincide with d, a unimolar fragment. The revertant 1704R, shown in lane 3, is identical to strain 17+, shown in lane 1. New Zealand White rabbits (3 to 3.5 kg) were inoculated in (Fig. 3 ).
An in vitro explant cocultivation reactivation time course of HSV-1 strains 17+, 1704, and 1704R is presented in Fig. 4 . Upon sacrifice, the trigeminal ganglia were minced and cocultivated on monolayers of secondary rabbit kidney cells and examined daily for cytopathic effects for up to 28 days. The LAT minus strain, 1704, reactivated more slowly and less efficiently than the parental virus from explanted rabbit trigeminal ganglia, as has been demonstrated in mouse model systems (13, 28 3, and 4) , parental 17+ (lane 5), and reactivated 17+ (lanes 6, 7, and 8) are shown. DNAs were resolved by agarose gel electrophoresis, transferred to nitrocellulose by Southern blotting, hybridized with 32p_ labeled, nick-translated HSV-1 (strain F) restriction fragment BamHI E (a gift of B. Roizman [19] ), washed, and autoradiographed by standard procedures (20) . Molecular sizes (in kilobases) are indicated at right. infected in one or both trigeminal ganglia), while the 1704 strain was recovered least frequently (8 of 22 [36%]) and 1704R was recovered from 12 of 15 (80%) animals ( Table 2 ). There appeared to be an inverse correlation between the incidence of isolating latent virus that had reactivated and the time required for reactivation; e.g., the 17+ virus was reactivated most frequently (40 of 41 [98%] of trigeminal ganglia) in a mean time period of 8.6 days, 1704 was reactivated least frequently (10 of 36 [28%] of trigeminal ganglia) while requiring 17.2 days for reactivation, and 1704R required 9 days to be reactivated, which was almost identical to the parent 17+ time of 8.6 days.
The advantages of the sensory ganglia/explant culture model are that reactivation is rapid and reproducible and the effect of treatments which might modify the reactivation process can be evaluated (26) . The limitation of explant reactivation is that it is an artificial manipulation of latently infected tissue. It can be used to study some aspects of reactivation, in this case the effect of the LAT gene on the time of appearance of reactivated virus. Explant cocultivation will not be useful for studying every aspect of reactivation; for example, it may not reflect the subtle interplay of host immune or wound-healing responses with viral factors. Host species and strain differences are known to affect the ability of HSV-1 to establish latency and to spontaneously reactivate in vivo (7, 8) . Recently, Gordon et al. (6) (13, 27) . HSV-1 variant 1704 expresses normal levels of the immediate early gene ICPO (27) , which suggests that the impaired reactivation of 1704 is not due to an effect on ICPO expression. In addition to the LAT deletion, HSV-1 variant 1704 is also glycoprotein C negative (32) . However, it has been shown that this glycoprotein C-negative phenotype is not related to the LAT gene or the impaired reactivation of 1704 (32) .
From studies of HSV-1 LAT+ and LAT-viruses in the rabbit model using both in vitro and in vivo reactivation techniques, the data support and extend previous conclusions that (i) LAT expression is not essential for HSV-1 replication in vitro or in vivo and (ii) LAT expression is not required for the establishment or maintenance of latent virus infection within trigeminal ganglia. The current work strengthens the hypothesis that the LATs play an important role in the reactivation of latent HSV-1. Furthermore, the trigeminal ganglia explant reactivation model (rabbit or mouse) complements the in vivo model of iontophoretically induced reactivation and may be of significant value in evaluating the reactivation behavior of genetically engineered LAT variants and in the molecular dissection of LAT function.
We express our appreciation to Jane Sindayen, Alma Abancio, and Cheryl McFadden for typing the manuscript and to Ann Dawson for editorial assistance.
This work was supported in part by Public Health Service grants EY02957 and EY03040 from the National Eye Institute and Al 23968 from the National Institute of Allergy and Infectious Diseases.
